- Home
- ASXC vs PMVP Comparison
ASXC vs PMVP Comparison
Compare ASXC & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASXC
- PMVP
- Stock Information
- Founded
- ASXC 2006
- PMVP 2013
- Country
- ASXC United States
- PMVP United States
- Employees
- ASXC N/A
- PMVP N/A
- Industry
- ASXC Medical/Dental Instruments
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ASXC Health Care
- PMVP Health Care
- Exchange
- ASXC Nasdaq
- PMVP Nasdaq
- Market Cap
- ASXC 92.6M
- PMVP 81.8M
- IPO Year
- ASXC N/A
- PMVP 2020
- Fundamental
- Price
- ASXC N/A
- PMVP $1.50
- Analyst Decision
- ASXC Hold
- PMVP Strong Buy
- Analyst Count
- ASXC 2
- PMVP 4
- Target Price
- ASXC $0.35
- PMVP $5.75
- AVG Volume (30 Days)
- ASXC 3.0M
- PMVP 239.7K
- Earning Date
- ASXC 08-13-2024
- PMVP 08-08-2024
- Dividend Yield
- ASXC N/A
- PMVP N/A
- EPS Growth
- ASXC N/A
- PMVP N/A
- EPS
- ASXC N/A
- PMVP N/A
- Revenue
- ASXC $9,850,000.00
- PMVP N/A
- Revenue This Year
- ASXC $43.43
- PMVP N/A
- Revenue Next Year
- ASXC $81.68
- PMVP N/A
- P/E Ratio
- ASXC N/A
- PMVP N/A
- Revenue Growth
- ASXC 39.05
- PMVP N/A
- 52 Week Low
- ASXC $0.17
- PMVP $1.18
- 52 Week High
- ASXC $0.40
- PMVP $6.98
- Technical
- Relative Strength Index (RSI)
- ASXC 14.59
- PMVP 43.58
- Support Level
- ASXC $0.29
- PMVP $1.51
- Resistance Level
- ASXC $0.35
- PMVP $1.63
- Average True Range (ATR)
- ASXC 0.01
- PMVP 0.07
- MACD
- ASXC -0.01
- PMVP -0.00
- Stochastic Oscillator
- ASXC 0.00
- PMVP 3.03
About ASXC Asensus Surgical Inc.
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.